Notes / Company

RPG Life Sciences Ltd.

RPGLIFE BSE 532983 ISIN INE105J01010 Pharmaceuticals

Fundamentals

Market cap: ₹3,765 cr
P/E: 32.69×
ROE: 34.54%
Debt / equity: 0.00
Div yield: 1.05%
52-week range: 1733.00 — 2725.00

Research on Tijori Finance

Company snapshot

RPG Life Sciences Ltd.

Pharmaceuticals

₹4,537 cr

P/E 39.39×

Latest quarter · Mar 2026

Sales₹177 cr

Net profit₹30 cr

Op. margin+18.6%

EPS₹18.08

Strength & growth

Debt / equity0.03×

Current ratio3.48×

Sales CAGR+9.7%

EPS CAGR+22.7%

The timeline — 1 note on RPG Life Sciences Ltd.

July 2026

13 Jul 26 · 12:39 PM IST Brief

Brief · Small cap

RPG Life Sciences, Archerchem launch Naprosyn ES combo in India

First-in-India fixed-dose combination of naproxen and esomeprazole targets long-term NSAID users. RPG Life Sciences will be the exclusive marketing and distribution partner.

Verify on exchange BSE filings for RPGLIFE NSE filings for RPGLIFE Tijori Finance company page